Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03145428 · ClinicalTrials.gov registry record
Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 3,000
- Enrollment target
NCT03145428: Completed study, sponsored by Beckman Coulter.
NCT03145428 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03145428 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
The measurement of monocyte volume width distribution (MDW) is intended for use with adult patients presenting to the emergency department (ED), where a CBC with Differential has been ordered, as an aid in the early detection of patients with or developing sepsis. The study will establish the clinical performance of MDW for detection of sepsis in the ED.
Primary Outcome
Determination of the diagnostic accuracy, area under the receiver operating characteristic curve
Interventions
- DIAGNOSTIC_TEST CBC-Diff Monocyte volume width distribution (MDW)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2017-06-19 |
| Est. Completion | 2018-01-26 |
What the finished NCT03145428 record still lists
NCT03145428 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which CBC-Diff Monocyte volume width distribution (MDW) is the first listed.
NCT03145428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03145428 about?
NCT03145428 is a clinical study titled "Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis". The measurement of monocyte volume width distribution (MDW) is intended for use with adult patients presenting to the emergency department (ED), where a CBC with Differential has been ordered, as an aid in the early detection of patients with or developing sepsis. The study will establish the clinic...
What is the current status of trial NCT03145428?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2017-06-19. Estimated completion is 2018-01-26.
What interventions are being tested in trial NCT03145428?
The interventions under investigation include: CBC-Diff Monocyte volume width distribution (MDW) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03145428?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI